###begin article-title 0
P-Glycoprotein Acts as an Immunomodulator during Neuroinflammation
###end article-title 0
###begin p 1
###xml 57 60 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 159 162 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
###xml 236 239 <span type="species:ncbi:12475?0.9718934911242604">HDV</span>
Conceived and designed the experiments: GK CD JMMdH TBHG HDV. Performed the experiments: GK RB JJK AR JvH SMAvdP JARD. Analyzed the data: GK RB JJK JMMdH TBHG HDV. Contributed reagents/materials/analysis tools: AHS. Wrote the paper: GK HDV.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system in which autoreactive myelin-specific T cells cause extensive tissue damage, resulting in neurological deficits. In the disease process, T cells are primed in the periphery by antigen presenting dendritic cells (DCs). DCs are considered to be crucial regulators of specific immune responses and molecules or proteins that regulate DC function are therefore under extensive investigation. We here investigated the potential immunomodulatory capacity of the ATP binding cassette transporter P-glycoprotein (P-gp). P-gp generally drives cellular efflux of a variety of compounds and is thought to be involved in excretion of inflammatory agents from immune cells, like DCs. So far, the immunomodulatory role of these ABC transporters is unknown.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 85 92 85 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
Here we demonstrate that P-gp acts as a key modulator of adaptive immunity during an in vivo model for neuroinflammation. The function of the DC is severely impaired in P-gp knockout mice (Mdr1a/1b-/-), since both DC maturation and T cell stimulatory capacity is significantly decreased. Consequently, Mdr1a/1b -/- mice develop decreased clinical signs of experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis. Reduced clinical signs coincided with impaired T cell responses and T cell-specific brain inflammation. We here describe the underlying molecular mechanism and demonstrate that P-gp is crucial for the secretion of pro-inflammatory cytokines such as TNF-alpha and IFN-gamma. Importantly, the defect in DC function can be restored by exogenous addition of these cytokines.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
Our data demonstrate that P-gp downmodulates DC function through the regulation of pro-inflammatory cytokine secretion, resulting in an impaired immune response. Taken together, our work highlights a new physiological role for P-gp as an immunomodulatory molecule and reveals a possible new target for immunotherapy.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 184 187 184 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Ewing1">[1]</xref>
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Lucchinetti1">[4]</xref>
###xml 352 355 352 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Hohlfeld1">[5]</xref>
###xml 644 647 644 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Steinman1">[6]</xref>
###xml 804 807 804 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Banchereau1">[7]</xref>
###xml 910 913 910 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Corinti1">[8]</xref>
###xml 915 918 915 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Quah1">[9]</xref>
Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system (CNS), characterized by the presence of demyelinated lesions throughout the brain [1]-[4]. Experimental autoimmune encephalomyelitis (EAE) is a widely accepted animal model for MS, sharing its clinical, immunological and pathological characteristics [5]. The mechanisms of CNS inflammation in MS and EAE involve generation of autoreactive, myelin specific T helper (Th) cells in the peripheral lymphoid organs, which subsequently enter the brain, initiate an immune response and eventually cause destruction of myelin sheaths and axonal loss [6]. Antigen-presenting cells like dendritic cells (DCs) are important regulators of immune responses by presenting their captured antigens to specific T cells [7]. In general, the maturation status of DCs is a key determinant of how the immune response will evolve [8], [9]. Molecules or proteins that regulate DC maturation and thereby control immune responses are under extensive investigation, since this may provide tools for immune modulation.
###end p 9
###begin p 10
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Bauer1">[10]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Loscher1">[11]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Juliano1">[12]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Thiebaut1">[13]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Frank1">[14]</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Frank1">[14]</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Raggers1">[19]</xref>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Randolph1">[20]</xref>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Pendse1">[21]</xref>
###xml 939 946 939 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
One possible candidate for immunomodulation is P-glycoprotein (P-gp; ABCB1), a well-known multi-drug resistance (MDR) efflux pump, which transports a variety of substrates and drugs through the membrane against a concentration gradient at the cost of ATP hydrolysis [10], [11]. P-gp was originally discovered as a prototypic transporter involved in MDR of tumor cells [12], and was the first drug efflux transporter to be detected on blood-brain barrier endothelial cells [13]. P-gp is also expressed on a variety of immune cells like monocytes, DCs, T and B cells [14] and is involved in the efflux of inflammatory molecules such as steroids, prostaglandins and cytokines [14]-[19], suggesting a function in immunomodulation. A limited number of studies have implied that P-gp can modulate immune responses by regulating the emigration of Langerhans cells to lymphoid organs [20] and APC maturation in vitro via IL-12 secretion [21], but in vivo relevance is lacking.
###end p 10
###begin p 11
###xml 237 244 237 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Schinkel1">[22]</xref>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
Despite the reports suggesting immune-related functions of P-gp, data on how P-gp exerts its action during immune responses remains unknown. Therefore, the goal of our study was to investigate the potential immunomodulatory role of P-gp in vivo. We here demonstrate that DCs from P-gp knockout mice (Mdr1a/1b-/-, [22]) are severely impaired in their maturation and T cell stimulatory capacity. Consequently, Mdr1a/1b-/- mice displayed reduced clinical signs of EAE, which coincided with decreased inflammation in the brain and an overall reduced T cell response. Taken together, our findings highlight a novel immunomodulatory role for P-gp, which may open new therapeutic avenues to interfere in the pathogenesis of (auto)immune-related or inflammatory diseases.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 13 17 <span type="species:ncbi:10090">Mice</span>
Mdr1a/1b -/- Mice Have Reduced Clinical Signs of EAE
###end title 13
###begin p 14
###xml 303 312 303 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g001">Figure 1a</xref>
###xml 314 321 314 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008212-t001">Table 1</xref>
###xml 437 446 437 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g001">Figure 1b</xref>
###xml 578 587 578 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008212.s001">Figure S1</xref>
###xml 779 790 779 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g002">Figure 2a,b</xref>
###xml 809 820 809 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g002">Figure 2e,f</xref>
###xml 844 852 844 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008212.s004">Table S3</xref>
###xml 901 902 901 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 982 993 982 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g002">Figure 2c,d</xref>
###xml 1012 1023 1012 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g002">Figure 2g,h</xref>
###xml 1043 1051 1043 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008212.s004">Table S3</xref>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 1177 1181 <span type="species:ncbi:10090">mice</span>
EAE was induced in Mdr1a/1b-/- and wild-type mice using recombinant myelin oligodendrocyte glycoprotein (rMOG). Notably, Mdr1a/1b -/- mice showed significantly reduced clinical signs of disease (*p<0.05) compared to wild-type animals during the acute (day 15) and progressive (day 29) phase of disease (Figure 1a, Table 1). Moreover, the total EAE score per animal was significantly lower in Mdr1a/1b-/- mice compared to wild-type mice (Figure 1b). The observed differences in clinical signs were associated with decreased demyelination in the brain of Mdr1a/1b-/- EAE animals (Figure S1). Decreased demyelination in Mdr1a/1b-/- animals coincided with diminished brain inflammation as determined by the reduced numbers of infiltrated macrophages in EAE lesions during the acute (Figure 2a,b) and progressive (Figure 2e,f) phase of disease (see Table S3 for a detailed overview). Notably, almost no CD3+ T cell infiltrates were observed in Mdr1a/1b -/- EAE lesions during the acute (Figure 2c,d) and progressive (Figure 2g,h) phase of disease (Table S3), suggesting that the immune response and in particular the specific T cell response is selectively affected in Mdr1a/1b -/- mice during EAE.
###end p 14
###begin title 15
###xml 26 37 26 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mdr1a/1b&#8722;/&#8722;</italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Reduced clinical signs in Mdr1a/1b-/- mice during acute and progressive phase of EAE.
###end title 15
###begin p 16
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 273 278 <span type="species:ncbi:10090">mouse</span>
(A) Clinical signs of EAE induced by immunization of wild-type (WT) and Mdr1a/1b-/- mice with rMOG (1-125) showing mean clinical scores (+/- SEM) of two independent experiments (*p<0.002 Mann-Whitney, n = 23 mice per group). (B) Mean total EAE score per WT or Mdr1a/1b -/- mouse. *p<0.05.
###end p 16
###begin title 17
###xml 32 43 32 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mdr1a/1b&#8722;/&#8722;</italic>
Decreased brain inflammation in Mdr1a/1b-/- EAE lesions.
###end title 17
###begin p 18
###xml 160 161 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 204 205 204 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 209 210 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
Brains were isolated from EAE mice on day 15 (A-D) and day 29 (E-H) after immunization and the cerebellum white matter was analyzed for the infiltration of CD45+ mac1+ macrophages (green; A,B,E,F) or CD45+ CD3+ T cells (green; C,D,G,H) and laminin positive (red) basement membranes around vessels in WT (left panel) or Mdr1a/1b-/- (right panel) mice. Images represent representative tissues from 4 mice per group. Magnification 200x.
###end p 18
###begin title 19
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Clinical characteristics of EAE in WT and mdr1a/1b -/- mice.
###end title 19
###begin p 20
###xml 22 26 <span type="species:ncbi:10090">mice</span>
p<0.05 compared to WT mice.
###end p 20
###begin title 21
###xml 44 48 <span type="species:ncbi:10090">Mice</span>
Reduced Th1 and Th2 Response in Mdr1a/1b-/- Mice during EAE
###end title 21
###begin p 22
###xml 448 459 448 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g003">Figure 3a,b</xref>
###xml 540 551 532 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g003">Figure 3c&#8211;f</xref>
###xml 587 598 579 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g003">Figure 3g&#8211;j</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 883 887 <span type="species:ncbi:10090">mice</span>
To determine whether T cell responses to rMOG were reduced in Mdr1a/1b-/- mice, we compared the proliferative capacity and cytokine secretion of lymph node cells from Mdr1a/1b-/- and wild-type animals at different time points of EAE. Interestingly, lymph node cells from rMOG-immunized Mdr1a/1b-/- mice showed significantly impaired MOG specific T cell proliferation during the acute and progressive phase of disease compared to wild-type animals (Figure 3a,b). Furthermore, MOG specific secretion of Th1 cytokines IFN-gamma and TNF-alpha (Figure 3c-f) and Th2 cytokines IL-10 and IL-5 (Figure 3g-j) by lymph node cells was significantly decreased in rMOG-immunized Mdr1a/1b-/- mice compared to wild-type animals, whereas no changes were observed in the secretion of the Th17 cytokine IL-17 (data not shown). These results demonstrate a decreased Th1 and Th2 response in Mdr1a/1b-/- mice compared to wild-type animals upon immunisation with rMOG.
###end p 22
###begin title 23
###xml 33 44 33 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mdr1a/1b&#8722;/&#8722;</italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Impaired Th1 and Th2 response in Mdr1a/1b-/- mice during EAE.
###end title 23
###begin p 24
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
T cell proliferation in lymph node cells isolated from wild-type (WT) and Mdr1a/1b-/- mice was assessed upon re-stimulation with different concentrations of rMOG (1-125) on day 15 (A) or day 29 (B) of EAE. Supernatants from T cell proliferation assays upon re-stimulation with 10 microg/ml rMOG (1-125) were harvested and the production of the Th1 cytokines IFN-gamma (C,D) or TNF-alpha (E,F) and the Th2 cytokines IL-10 (G,H) or IL-5 (I,J) was measured on different time points (48, 72 and 96 hr). Experiments were performed in triplicate using 4 mice per group and were presented as the mean +/- SEM. *p<0.05, **p<0.01.
###end p 24
###begin title 25
P-gp Regulates Inflammatory Cytokine Extrusion but Not Polyclonal T Cell Activation
###end title 25
###begin p 26
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 71 79 71 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g002">Figure 2</xref>
###xml 261 262 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Li1">[23]</xref>
###xml 409 420 409 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g004">Figure 4a,b</xref>
###xml 482 483 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 491 492 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 761 770 753 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g004">Figure 4c</xref>
###xml 960 969 944 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g004">Figure 4d</xref>
###xml 1049 1050 1029 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1060 1069 1040 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g004">Figure 4e</xref>
###xml 1077 1078 1057 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1088 1097 1068 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g004">Figure 4f</xref>
###xml 1481 1484 1461 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Banchereau1">[7]</xref>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
Reduced brain infiltration of CD3+ T cells in Mdr1a/1b-/- EAE lesions (Figure 2) and a reduced T cell response to rMOG in Mdr1a/1b-/- mice suggests that the activation status of these T cells is impaired. To test this, we assessed the activation capacity of CD4+ and CD8+ T cells upon stimulation with anti-CD3/anti-CD28 [23]. No differences in the expression of T cell activation markers like CD44 and CD69 (Figure 4a,b) or CD25 and CD62L (data not shown) were observed between CD4+ and CD8+ T cells from Mdr1a/1b-/- and wild-type mice after anti-CD3/anti-CD28 stimulation. However, anti-CD3/anti-CD28 stimulation of Mdr1a/1b -/- lymph node cells resulted in a reduced release of the inflammatory cytokines TNF-alpha and IFN-gamma compared to wild-type cells (Figure 4c). In contrast, no differences were observed in the production of IFN-gamma or TNF-alpha transcripts after anti-CD3/anti-CD28 stimulation between wild-type and Mdr1a/1b-/- lymph node cells (Figure 4d), which correlated with no differences in intracellular IFN-gamma levels in CD4+ T cells (Figure 4e) or CD8+ T cells (Figure 4f). Together, these results indicate that P-gp is involved in the cellular extrusion of inflammatory cytokines from lymph node cells but not its cellular production. Moreover, P-gp does not affect the ability of T cells to become activated, pointing to a distinct mechanism during EAE pathology. As DCs are crucial mediators of immune responses by regulating specific T cell responses [7], P-gp may perform its immunomodulatory function predominantly on DCs during DC-induced T cell responses.
###end p 26
###begin title 27
P-gp does not affect polyclonal T cell activation.
###end title 27
###begin p 28
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 494 495 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 506 507 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
Lymph node cells isolated from WT and Mdr1a/1b-/- mice were stimulated with anti-CD3/anti-CD28 for 5 hr and subsequently stained for T cell activation markers CD69 (A) or CD44 (B) on live cell gated CD4+ or CD8+ T cells. After anti-CD3/anti-CD28 stimulation, cytokine production of IFN-gamma, TNF-alpha or IL-10 was measured (C) and IFN-gamma and TNF-alpha transcripts were detected by RT-PCR and presented as relative expression compared to GAPDH (D). Intracellular IFN-gamma production in CD4+ (E) or CD8+ T cells (F) was determined on permeabilized lymph node cells after anti-CD3/anti-CD28 stimulation. Experiments were performed in triplicate using 5 mice per group and were presented as the mean +/- SEM. *p<0.05, **p<0.01.
###end p 28
###begin title 29
Specific P-gp Blockade Inhibits T Cell Proliferation during DC-T Cell Interactions
###end title 29
###begin p 30
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 327 335 327 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Koubeissi1">[24]</xref>
###xml 405 416 405 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g005">Figure 5a,b</xref>
###xml 645 646 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 654 655 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 678 689 670 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g005">Figure 5g,h</xref>
###xml 721 732 713 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g005">Figure 5i&#8211;l</xref>
To determine the exact role of P-gp during antigen presentation and DC-induced T cell responses, we investigated DC-induced proliferation of ovalbumin-specific CD8+ (OTI) and CD4+ (OTII) T cells during P-gp blockade. CD4+ and CD8+ T cell proliferation to OVA-loaded BMDCs was strikingly decreased in the presence of a specific in vitro P-gp inhibitor (reversin 121; 200 nM; [24]) compared to its vehicle (Figure 5a,b). Secretion of IFN-gamma and TNF-alpha (Th1 cytokines) was significantly decreased during P-gp inhibited T cell proliferation on different time points (5c-f). Notably, fixation of BMDCs showed no effect of P-gp inhibition on CD4+ and CD8+ T cell proliferation (Figure 5g,h) or on Th1 cytokine secretion (Figure 5i-l). These results strongly suggest that P-gp on T cells and DCs is required for secretion of inflammatory cytokines like IFN-gamma and TNF-alpha, thereby influencing specific T cell responses. However, as fixation of DCs prevented the P-gp inhibitory effect during T cell proliferation, it is likely that P-gp may exert its dominant role on DCs during immune responses.
###end p 30
###begin title 31
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
P-gp is necessary for CD4+ and CD8+ T cell proliferation.
###end title 31
###begin p 32
###xml 64 71 64 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">257&#8211;264</sub>
###xml 99 106 99 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">323&#8211;339</sub>
Bone marrow derived DCs (BMDCs) were coated with MHC class I OVA257-264 peptide or MHC class II OVA323-339 peptide and were used as stimulators for T cell proliferation. For this, titrated BMDCs were cultured with purified OT-I (A) or OT-II (B) in the presence or absence of the P-gp inhibitor reversin 121 (10 microM) or its vehicle DMSO (0.1%). Cytokine production of IFN-gamma (C,D) or TNF-alpha (E,F) was measured after 48 hr of co-culture. OVA peptide coated BMDCs were fixated with 0.1% PFA for 10 minutes after which OT-I (G) or OT-II (H) proliferation was measured together with IFN-gamma (I,J) or TNF-alpha (K,L) production after 48 hr of co-culture. Representative results are depicted as the mean +/- SEM from three independent experiments performed in triplo. *p<0.05, **p<0.01, ***p<0.001.
###end p 32
###begin title 33
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
Impaired DC Maturation in Mdr1a/1b -/- Mice
###end title 33
###begin p 34
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Greter1">[25]</xref>
###xml 354 362 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g001">Figure 1</xref>
###xml 363 363 363 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g002"/>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g003">3</xref>
###xml 634 643 634 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g006">Figure 6a</xref>
###xml 883 884 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 890 901 890 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g006">Figure 6a&#8211;e</xref>
###xml 1064 1068 1060 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Frank1">[14]</xref>
###xml 1070 1074 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Drach1">[16]</xref>
###xml 1375 1386 1363 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008212-g006">Figure 6f&#8211;i</xref>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
During pathogenic immune responses like EAE, DCs undergo maturation upon capture and presentation of antigens to T cells in lymphoid organs and in perivascular spaces surrounding the cerebral vessels [25]. In Mdr1a/1b-/- mice we observed a decreased brain infiltration of T cells and an impaired T cell response during EAE compared to wild-type animals (Figure 1-3). To assess whether this was due to diminished DC maturation, we generated BMDCs from Mdr1a/1b-/- and wild-type mice and stimulated them with lipopolysaccharide (LPS). Unstimulated BMDCs from Mdr1a/1b-/- mice displayed a more immature DC phenotype than wild-type mice (Figure 6a) as determined by a lower level of expression of co-stimulatory molecules CD40, CD80, CD86 and MHCII on CD11c+ DCs (6b-e). Stimulation with LPS resulted in a strongly decreased DC maturation in mdr1a/1b-/- cells compared to wild-type CD11c+ DCs (Figure 6a-e). Various cytokines are known to be involved in DC maturation processes and as P-gp may be involved in the cellular extrusion of various cytokines like IFN-gamma [14], [16], we therefore hypothesize that the decreased maturation ability of Mdr1a/1b -/- DCs is due to lower efflux of various cytokines during DC maturation. Addition of exogenous TNF-alpha and IFN-gamma together enhanced DC maturation and completely restored the effect of blocking P-gp after LPS addition (Figure 6f-i), whereas addition of these cytokines separately did not affect DC maturation (data not shown). These data strongly suggest that P-gp is crucial in DC function by controlling DC maturation and subsequent T cell activation through cytokine secretion.
###end p 34
###begin title 35
P-gp mediates DC maturation via IFN-gamma and TNF-alpha secretion.
###end title 35
###begin p 36
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
(A) DC maturation of BMDCs isolated from WT (shaded histogram) or Mdr1a/1b-/- (open histogram) mice were determined by the expression of CD40, CD80, CD86 or MHCII on live cell gated and CD11c+ cells in the presence or absence of LPS. Quantification of DC maturation of CD11c+ cells positive for CD40 (B), CD80 (C), CD86 (D) and MHCII (E). Recombinant IFN-gamma or TNF-alpha (5 ng/ml) was added to BMDCs derived from C57Bl/6 mice cultured in the presence or absence of LPS, the P-gp inhibitor reversin 121 (10 microM) or its vehicle DMSO (0.1%). Experiments were performed in triplicate using 5 mice per group (A-E) or three independent experiments (F-I) and were presented as the mean +/- SEM. *p<0.05.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
Here, we demonstrate a novel in vivo physiological role for P-gp as a key regulator of immune responses by controlling DC maturation and subsequent DC-induced T cell responses. We here show that P-gp knockout mice (Mdr1a/1b-/-) displayed reduced clinical signs of EAE compared to wild-type animals. Observed differences were associated with decreased brain inflammation, CNS demyelination and an overall reduced T cell response in Mdr1a/1b-/- animals during disease.
###end p 38
###begin p 39
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 398 401 398 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Hohlfeld1">[5]</xref>
###xml 449 450 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 542 546 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Weiss1">[26]</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
Interestingly, we observed reduced infiltration of CD3+ T cells into the brains of Mdr1a/1b-/- EAE lesions, which correlated with diminished clinical signs of EAE and an impaired T cell response in Mdr1a/1b-/- mice compared to wild-type mice. EAE is a T cell-mediated CNS autoimmune disease widely used as an animal model of MS, sharing its clinical, immunological and pathological characteristics [5]. Like MS, EAE is originally thought to be a CD4+ T cell mediated disease, although evidence is emerging for a crucial role for CD8+ T cells [26]. Notably, lymph node cells from rMOG-immunized Mdr1a/1b-/- mice showed significantly impaired MOG specific T cell proliferation during EAE compared to wild-type animals, whereas a polyclonal stimuli like PMA/ionomycin showed no significant differences (unpublished data). Diminished proliferation coincided with decreased Th1 and Th2, but not Th17 cytokine levels. These results suggest that P-gp is involved in Th1 and Th2 responses during EAE and point to an overall impaired T cell response in Mdr1a/1b-/- animals during EAE.
###end p 39
###begin p 40
###xml 632 636 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Eisenbraun1">[27]</xref>
###xml 1291 1294 1283 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Banchereau1">[7]</xref>
###xml 1354 1358 1346 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Frank1">[14]</xref>
###xml 1360 1364 1352 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Randolph1">[20]</xref>
###xml 1366 1370 1358 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Schroeijers1">[28]</xref>
###xml 1411 1415 1403 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Pendse1">[21]</xref>
###xml 1514 1515 1506 1507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1523 1524 1515 1516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1718 1719 1702 1703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1727 1728 1711 1712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1995 1999 1975 1979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Drach1">[16]</xref>
###xml 2020 2024 2000 2004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Frank1">[14]</xref>
###xml 2026 2030 2006 2010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Pendse1">[21]</xref>
###xml 2215 2219 2195 2199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Fukao1">[29]</xref>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 1322 1327 <span type="species:ncbi:10090">mouse</span>
###xml 1332 1337 <span type="species:ncbi:9606">human</span>
Reduced clinical signs in Mdr1a/1b -/- mice during EAE may be caused by an altered immune response to myelin proteins in these animals. During the acute and progressive phase of EAE, we observed less brain infiltrating T cells in Mdr1a/1b -/- EAE lesions. These results strongly imply that the ability of Mdr1a/1b -/- T cells to become activated during immune responses is impaired. However, anti-CD3/anti-CD28 stimulation of T cells from Mdr1a/1b -/- displayed a normal activation capacity, indicating that P-gp on T cells is not required for T cell activation responses, which has previously been suggested for Mdr1a encoded P-gp [27]. Interestingly, anti-CD3/anti-CD28 stimulation of Mdr1a/1b -/- lymph node cells resulted in a reduced release of the inflammatory cytokines TNF-alpha and IFN-gamma compared to wild-type cells, whereas the level of intracellular cytokines or transcripts remained unaffected. These results strongly indicate that P-gp mediates the cellular extrusion of inflammatory cytokines from lymph node cells but not its cellular production. As P-gp does not affect the ability of T cells to become activated, the observed differences in T cell responses during EAE may be initiated by P-gp on DCs, as these cells are crucial mediators in regulating T cell responses [7]. P-gp is expressed on both mouse and human T cells and DCs [14], [20], [28] and is upregulated during DC maturation [21]. We here demonstrate that blocking P-gp during DC-induced T cell activation prevented specific CD4+ and CD8+ T cell proliferation, which was accompanied by reduced secretion of proinflammatory cytokines TNF-alpha and IFN-gamma. Notably, fixation of DCs restored the inhibitory effect of P-gp during CD4+ and CD8+ T cell proliferation, demonstrating a crucial role for P-gp on DCs for T cell activation via cytokine secretion. P-gp has previously been reported to be involved either directly or indirectly in the extrusion of proinflammatory cytokines like IFN-gamma from T cells [16], and IL-12 from DCs [14], [21]. Autocrine IL-12 is necessary for IFN-gamma production by DCs and the production of IL-12 during DC-induced T cell responses can influence DC induction of a Th1 or Th2 immune response [29], which in turn may be responsible for the observed reduced levels of IFN-gamma in our assays. However, in our studies levels of IL-12 were too low to detect differences between Mdr1a/1b -/- and wild-type animals (unpublished results). Together, these results imply an important role for P-gp in DC function and subsequent DC-induced T cell responses through regulation of cytokine excretion.
###end p 40
###begin p 41
###xml 132 135 132 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Quah1">[9]</xref>
###xml 378 379 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 487 494 487 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1061 1065 1053 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Frank1">[14]</xref>
###xml 1067 1071 1059 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Drach1">[16]</xref>
###xml 1073 1077 1065 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Pendse1">[21]</xref>
###xml 1195 1199 1187 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Raggers1">[19]</xref>
###xml 1258 1262 1246 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Huang1">[30]</xref>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
The maturation status of DCs is a key determinant of how the immune response will evolve as it determines specific T cell responses [9]. We here show that DCs that lack P-gp function, either genetically or pharmacologically, have decreased levels of maturation, as determined by the expression of co-stimulatory molecules like CD40, CD80, CD86 and MHC class II antigens on CD11c+ DCs. Reduced DC maturation in Mdr1a/1b -/- animals can contribute to the impaired immune response observed in vivo during EAE, thereby demonstrating a pivotal role for P-gp as an immunomodulatory molecule. Interestingly, we are the first to show a defective DC phenotype in Mdr1a/1b-/- mice as determined by an impaired DC maturation capacity. We postulate that P-gp mediates DC maturation by influencing the excretion of proinflammatory cytokines like TNF-alpha and IFN-gamma as lower levels of these cytokines were detected during DC-T cell interactions. However, a controversial issue remains whether P-gp itself is capable of transporting cytokines as suggested by some groups [14], [16], [21] or that P-gp is involved in the secretion of other relevant physiological substrates like platelet activating factor [19] that in turn may affect cytokine secretion like IFN-gamma [30] as a secondary effect. Nevertheless, addition of TNF-alpha and IFN-gamma to P-gp deficient DCs restored their maturation capacity, highlighting an important role for P-gp and these cytokines during DC maturation and subsequent immune responses.
###end p 41
###begin p 42
###xml 89 96 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Fukao1">[29]</xref>
###xml 572 579 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1134 1138 1123 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Hussien1">[31]</xref>
###xml 1140 1144 1129 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Vieira1">[32]</xref>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 1095 1103 <span type="species:ncbi:9606">patients</span>
Together, we here demonstrate an impaired adaptive immunity response in Mdr1a/1b-/- mice in vivo, as these mice develop reduced clinical signs of EAE. Reduced clinical signs coincided with decreased levels of DC maturation and impaired DC-induced T cell responses. DCs regulate Th1 and Th2 responses by the production of various cytokines [29], and we hypothesize that P-gp mediates DC maturation and T cell responses by influencing the extrusion of proinflammatory cytokines like TNF-alpha and IFN-gamma, thereby regulating immune responses. Our results indicate a novel in vivo physiological role for P-gp during immune processes, which may open new avenues for the treatment of various immune mediated diseases. Based on our results, the prime target for the treatment of MS is affecting P-gp on DCs by immunotherapy, as DCs are ideal tools for immunotherapeutic strategies due to their intrinsic capacity to efficiently present antigens to T cells thereby regulating T cell responses. Interestingly, two compounds, IFN-beta and glatiramer acid (GA) that are widely used in the clinic for MS patients have DCs as potential targets [31], [32]. In conclusion, our work highlights a new immunomodulatory role of P-glycoprotein in adaptive immunity and reveals a new target for immunotherapy to suppress adaptive immunity during immune responses and neuroinflammation.
###end p 42
###begin title 43
Materials and Methods
###end title 43
###begin title 44
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 44
###begin p 45
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Lagas1">[33]</xref>
###xml 657 664 650 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">257&#8211;264</sub>
###xml 695 696 688 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 708 715 701 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">323&#8211;339</sub>
###xml 745 746 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
Female Mdr1a/1b-/- and wild type (FVB) mice, 8-12-week of age, were kindly provided by dr. Alfred Schinkel (NKI Amsterdam). Mdr1a/1b-/- mice showed no indications for spontaneous colitis after extensive pathological screening and displayed no differences in BBB permeability for non-P-gp substrates [33]. Female C57BL/6-J or C57BL/6-N mice, 7-12 weeks of age, were obtained from Charles River (L'Arbresle, France) or Janvier (France), respectively. OT-I and OT-II mice were bred at the animal facility of the VU University Medical Center (Amsterdam, The Netherlands). OT-I and OT-II mice have transgenic Valpha2Vbeta5 T cell receptors that recognize the OVA257-264 peptide in the context of H2-Kb and the OVA323-339 peptide in the context of I-Ab, respectively. All mice were kept under specific pathogen-free conditions and used in accordance with local animal experimentation guidelines.
###end p 45
###begin title 46
###xml 57 61 <span type="species:ncbi:10090">Mice</span>
Induction of Chronic EAE in Mdr1a/1b and Wild-Type (FVB) Mice
###end title 46
###begin p 47
###xml 209 213 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Adelmann1">[34]</xref>
###xml 350 376 342 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 607 627 595 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 1037 1038 1021 1022 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1041 1042 1025 1026 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 288 291 <span type="species:ncbi:31658">CFA</span>
###xml 350 382 <span type="species:ncbi:419947">Mycobacterium tuberculosis H37Ra</span>
###xml 406 409 <span type="species:ncbi:31658">CFA</span>
###xml 456 459 <span type="species:ncbi:31658">CFA</span>
###xml 607 627 <span type="species:ncbi:520">Bordetella pertussis</span>
###xml 743 747 <span type="species:ncbi:10090">Mice</span>
###xml 997 1001 <span type="species:ncbi:10090">Mice</span>
EAE was induced in 8-12-week-old female Mdr1a/1b-/- and wild type (FVB) mice via subcutaneous immunization with 200 microg recombinant myelin oligodendrocyte glycoprotein (rMOG 1-125; synthesized as described [34]) in an emulsion mixed (volume ratio 1:1) with Complete Freund's Adjuvant (CFA; Difco Laboratories) containing 500 microg of heat-killed Mycobacterium tuberculosis H37Ra (MBT; Difco). Control (CFA) animals were injected with saline mixed with CFA containing 500 microg of heat-killed MBT. All animals were additionally intraperitoneally (i.p.) injected with 200 ng pertussis toxin derived from Bordetella pertussis (Sigma, Zwijndrecht, The Netherlands) in 200 microL saline at the time of, and after 24 hr following immunization. Mice (n = 23 per group) were examined daily for clinical signs of EAE and were scored as followed: 0, no disease; 1, limp tail; 2, hindlimb weakness; 3, complete hindlimb paralysis; 4, hindlimb paralysis plus forelimb paralysis; and 5, moribund or dead. Mice were killed at day 15 or 29 using O2/CO2. All experimental procedures were reviewed and approved by the Ethical Committee for Animal Experiments of the VU University Medical Center (Amsterdam, The Netherlands)
###end p 47
###begin title 48
Histology and Immunohistochemistry
###end title 48
###begin p 49
###xml 694 698 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Floris1">[35]</xref>
###xml 700 704 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Schreibelt1">[36]</xref>
###xml 741 749 731 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008212.s002">Table S1</xref>
###xml 515 520 <span type="species:ncbi:10090">mouse</span>
###xml 643 649 <span type="species:ncbi:9913">bovine</span>
###xml 1071 1075 <span type="species:ncbi:9925">goat</span>
###xml 1081 1087 <span type="species:ncbi:9986">rabbit</span>
Four animals per group were sacrificed for T cell proliferation and histological examination on the peak of disease (day 15) and at the end of disease (day 29). Brains of sacrificed animals were dissected, snap-frozen in liquid nitrogen, and stored at -80degreesC. Kluver-Barrera (Luxol fast blue/cresyl violet) staining was performed on cryostat sections (5 microm) as described (Breij et al, 2005). For immunohistochemistry, cryostat sections were fixed in ice-cold acetone for 10 minutes and blocked with normal mouse serum (NMS) prior to antibody staining. Immunofluorescence staining was performed in PBS, supplemented with 0.1% (wt/vol) bovine serum albumin (BSA) as previously described [35], [36] and all antibodies are described in Table S1. Monoclonal conjugated antibodies for CD3, CD4 or CD8 were used to detect infiltrated T cells and monocyte infiltration was detected with the conjugated monocyte/macrophage marker mac-1. Cerebral blood vessels were detected with an unconjugated polyclonal antibody directed against laminin and binding was revealed using goat anti-rabbit Alexa Fluor(R) 546 (Invitrogen). Sections were rinsed, dried, and mounted in Vectamount (Vector Laboratories). Immunofluorescent sections were enclosed in Vinol (Air Products, Allentown, USA) supplemented with DAPI (Invitrogen) and analyzed on a Leica DM6000 fluorescence microscope (Leica Microsystems, Heidelberg, Germany), equipped with LAS AF (Leica) software.
###end p 49
###begin title 50
Immune Cell Activation Assays and Cytokine Analysis
###end title 50
###begin p 51
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Backer1">[37]</xref>
###xml 550 551 546 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 695 696 687 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 281 285 <span type="species:ncbi:9913">calf</span>
###xml 854 859 <span type="species:ncbi:10090">mouse</span>
Lymph node cells (1x106 or 0,5x106 cells/well respectively) were isolated as described [37] and were cultured in flat-bottomed, 96-well plates in media (IMDM supplemented with 2 mM L-glutamine, 100 U ml-1 penicillin, 0.1 mg ml-1 streptomycin, 0.5 M 2-mercaptoethanol and 10% fetal calf serum). Cells were subsequently stimulated with rMOG (1-125) in various concentrations (3-30 microg/ml). As a positive control, cells were stimulated with PMA (20 ng/ml; Sigma)/ionomycin (500 ng/ml; Sigma). To assess proliferation rate, cultures were pulsed with [3H]-thymidine (1 microCi/well) after 48 h of culture and harvested 18 h later onto filter paper. The counts per minute (c.p.m.) of incorporated [3H]-thymidine were measured on a Wallac-LKB Betaplate 1205 liquid scintillation counter. Cytokines were measured in the supernatants of cultured cells using a mouse inflammation CBA kit (BD Pharmingen). Supernatants were taken at four different time points after stimulation (24, 48, 72 and 96 hrs). For lymph node activation assays, cells were pooled from four animals per group and triplicate wells plated.
###end p 51
###begin title 52
In Vitro Ag-Presentation Assays
###end title 52
###begin p 53
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-Inaba1">[38]</xref>
###xml 176 183 172 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">257&#8211;264</sub>
###xml 235 242 227 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">323&#8211;339</sub>
###xml 381 382 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 624 625 612 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 641 642 629 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 918 919 906 907 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 974 975 958 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1027 1028 1011 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 604 619 <span type="species:ncbi:10090">transgenic mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
Bone marrow derived DCs (BMDCs) were isolated and cultured in the presence of GM-CSF as described previously [38]. BMDCs were coated with 1 microg/ml MHC class I-restricted OVA257-264 peptide or 10 microg/ml MHC class II-restricted OVA323-339 peptide for 30 minutes and washed three times and control or fixated (PFA 0.1%, 10 min) BMDCs used as stimulators for naive T cells in a [3H]-thymidine incorporation assay in the presence or absence of the in vitro P-gp inhibitor reversin 121 (10 microM; Alexis) or its vehicle DMSO (0.1%). T cells were obtained from spleen and lymph nodes from OT-I and OT-II transgenic mice. CD8+ T cells and CD4+ T cells were purified by negative depletion using bead-based T cell isolation kits (Dynal Biotec ASA, Oslo, Norway) from OT-I and OT-II mice, respectively, following manufacturer's protocols. Purity of T cell preparations was between 80 and 90%. After 48 h incubation in a CO2 incubator, plates were pulsed with 1 microCi/well of [3H]-thymidine. After additional 16 h of incubation, [3H]-thymidine incorporation was measured on a Wallac-LKB Betaplate 1205 liquid scintillation counter. Experiments were performed in triplicate and presented as the mean +/- SEM.
###end p 53
###begin title 54
T Cell Activation
###end title 54
###begin p 55
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 189 197 189 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008212.s002">Table S1</xref>
Lymph node cells were stimulated with anti-CD3 (10 ug/ml)/anti-CD28 (2 ug/ml) for 5 hr. Cell surface expression of CD44, CD69, CD62L, CD25 was determined by gating on CD4+ or CD8+ T cells (Table S1). All staining procedures were performed using ice-cold PBS containing 1% BSA and 0.02% Na-azide. Intracellular IFN-gamma expression was determined by permeabilization and staining of cells with reagents provided in the Cytofix/Cytoperm kit according to the manufacturer's instructions (BD Pharmingen). Flow cytometry was performed on a FACSCaliburtrade mark with the use of CELLQuesttrade mark software (Becton Dickinson, Franklin Lakes, NJ) with auto-fluorescent cells excluded.
###end p 55
###begin title 56
BMDC Maturation
###end title 56
###begin p 57
###xml 363 371 351 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008212.s002">Table S1</xref>
###xml 126 131 <span type="species:ncbi:10090">mouse</span>
BMDC were stimulated with or without LPS in the absence or presence of the P-gp inhibitor reversin 121 (10 microM; Alexis) or mouse recombinant cytokines cytokines IFN-gamma and TNF-alpha (5 ng/ml; Peprotech). After 16 hrs, cells were washed with PBS/BSA 0.1% and stained for the expression of co-stimulatory molecules CD40, CD80, CD86 and MHCII on CD11c+ cells (Table S1). Cells were fixed in 2% PFA and flow cytometry was performed as described above.
###end p 57
###begin title 58
RNA Isolation and Real-Time Quantitative PCR
###end title 58
###begin p 59
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008212-GarciaVallejo1">[39]</xref>
###xml 386 394 386 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008212.s003">Table S2</xref>
Messenger RNA was isolated from control or stimulated (anti-CD3/anti-CD28 see above) lymph node cells using an mRNA capture kit (Roche) according to the manufacturer's instructions. cDNA was synthesized with the Reverse Transcription System kit (Promega, USA) following manufacturer's guidelines and RT-PCR was performed as described previously [39]. All primer sequences are listed in Table S2 and expression levels of transcripts obtained with real time PCR were normalized to GAPDH expression levels.
###end p 59
###begin title 60
Statistical Analysis
###end title 60
###begin p 61
###xml 34 38 <span type="species:ncbi:10090">mice</span>
EAE clinical scores for groups of mice are presented as the mean clinical score +/- s.e.m and statistical differences were analyzed by the Mann-Whitney U nonparametric ranking test. All other data were analyzed statistically by means of analysis of variance (ANOVA) and Student-Newman-Keuls test. Statistical significance was defined as *p<0.05, ** p<0.01, *** p<0.001.
###end p 61
###begin title 62
Supporting Information
###end title 62
###begin p 63
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
Decreased demyelination in mdr1a/1b-/- EAE lesions. Brains were isolated from non-immunized control mice (A) or EAE mice 29 days after immunization (B,C) and the cerebellum white matter was analyzed for demyelination using Kluver-Barrera staining in control (A), WT (B) or mdr1a/1b-/- (C) mice. Arrows indicate demyelinated areas and arrowheads indicate infiltrated leukocytes. Images represent representative tissues from 4 mice per group. Magnification 10x.
###end p 63
###begin p 64
(0.90 MB TIF)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
(0.02 MB DOC)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
(0.02 MB DOC)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
(0.02 MB DOC)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin title 72
References
###end title 72
###begin article-title 73
Insights into the aetiology and pathogenesis of multiple sclerosis.
###end article-title 73
###begin article-title 74
Multiple sclerosis-the plaque and its pathogenesis.
###end article-title 74
###begin article-title 75
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.
###end article-title 75
###begin article-title 76
Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment.
###end article-title 76
###begin article-title 77
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.
###end article-title 77
###begin article-title 78
Multiple sclerosis: a two-stage disease.
###end article-title 78
###begin article-title 79
Dendritic cells and the control of immunity.
###end article-title 79
###begin article-title 80
Regulatory activity of autocrine IL-10 on dendritic cell functions.
###end article-title 80
###begin article-title 81
Maturation of function in dendritic cells for tolerance and immunity.
###end article-title 81
###begin article-title 82
Modulation of p-glycoprotein transport function at the blood-brain barrier.
###end article-title 82
###begin article-title 83
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
###end article-title 83
###begin article-title 84
###xml 55 70 <span type="species:ncbi:10029">Chinese hamster</span>
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.
###end article-title 84
###begin article-title 85
Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.
###end article-title 85
###begin article-title 86
###xml 47 52 <span type="species:ncbi:9606">human</span>
Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro.
###end article-title 86
###begin article-title 87
Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells.
###end article-title 87
###begin article-title 88
###xml 123 128 <span type="species:ncbi:9606">human</span>
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes.
###end article-title 88
###begin article-title 89
###xml 87 92 <span type="species:ncbi:9606">human</span>
Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells.
###end article-title 89
###begin article-title 90
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.
###end article-title 90
###begin article-title 91
Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor.
###end article-title 91
###begin article-title 92
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels.
###end article-title 92
###begin article-title 93
P-glycoprotein functions as a differentiation switch in antigen presenting cell maturation.
###end article-title 93
###begin article-title 94
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.
###end article-title 94
###begin article-title 95
CD3- and CD28-dependent induction of PDE7 required for T cell activation.
###end article-title 95
###begin article-title 96
Inhibition of P-glycoprotein-mediated multidrug efflux by aminomethylene and ketomethylene analogs of reversins.
###end article-title 96
###begin article-title 97
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.
###end article-title 97
###begin article-title 98
CD8+ T cells in inflammatory demyelinating disease.
###end article-title 98
###begin article-title 99
###xml 134 138 <span type="species:ncbi:10090">mice</span>
mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice.
###end article-title 99
###begin article-title 100
Up-regulation of drug resistance-related vaults during dendritic cell development.
###end article-title 100
###begin article-title 101
Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses.
###end article-title 101
###begin article-title 102
Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism.
###end article-title 102
###begin article-title 103
Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis.
###end article-title 103
###begin article-title 104
Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells.
###end article-title 104
###begin article-title 105
P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin.
###end article-title 105
###begin article-title 106
###xml 154 157 <span type="species:ncbi:10116">rat</span>
The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.
###end article-title 106
###begin article-title 107
Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study.
###end article-title 107
###begin article-title 108
Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity.
###end article-title 108
###begin article-title 109
###xml 50 74 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
CD8- dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens.
###end article-title 109
###begin article-title 110
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
###end article-title 110
###begin article-title 111
Approach for defining endogenous reference genes in gene expression experiments.
###end article-title 111
###begin p 112
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 112
###begin p 113
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Netherlands Organization of Scientific Research (grant 016.046.314, G. Kooij, A. Reijerkerk; grant 917.46.311, J. den Haan, R. Backer), a VICI grant (918.56.612, J. Koning) and grants from the Dutch foundation of MS Research, The Netherlands (grant MS 05-567, J. van Horssen and J. Drexhage; grant MS 05-358c, J. van Horssen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 113

